{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:15:34Z","timestamp":1787170534281,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ophtha.2023.05.004","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T14:05:57Z","timestamp":1683641157000},"page":"958-965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Side Effects of Proton Beam Radiotherapy Treatment on Iris Melanoma"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9107-9196","authenticated-orcid":false,"given":"Katharina","family":"Eibenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Gatchalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2434-2924","authenticated-orcid":false,"given":"Andrzej","family":"Kacperek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8208-5009","authenticated-orcid":false,"given":"Rumana","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2023.05.004_bib1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1755-3768.1970.tb06592.x","article-title":"Malignant melanomas of the human uvea. Recent follow-up of cases in Denmark, 1943-1952","volume":"48","author":"Jensen","year":"1970","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.ophtha.2023.05.004_bib2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ajo.2011.11.004","article-title":"Clinical and ultrasound biomicroscopy features associated with growth in iris melanocytic lesions","volume":"153","author":"Giuliari","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.05.004_bib3","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/S0161-6420(95)30765-8","article-title":"Initial management and follow-up of melanocytic iris tumors","volume":"102","author":"Harbour","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.05.004_bib4","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/archopht.118.11.1515","article-title":"Iris and ciliary body melanomas: ultrasound biomicroscopy with histopathologic correlation","volume":"118","author":"Marigo","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.05.004_bib5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bjo.85.7.848","article-title":"Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment","volume":"85","author":"Conway","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.05.004_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0161-6420(00)00449-8","article-title":"Iris melanoma: risk factors for metastasis in 169 consecutive patients","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.05.004_bib7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/bjophthalmol-2017-310688","article-title":"Ruthenium-106 brachytherapy for iris and iridociliary melanomas","volume":"102","author":"Marinkovic","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.05.004_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ophtha.2012.06.053","article-title":"Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes","volume":"120","author":"Shields","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.05.004_bib9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/bjophthalmol-2013-303321","article-title":"Recurrence of iris melanoma after proton beam therapy","volume":"98","author":"Sandinha","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.05.004_bib10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0002-9394(02)02241-9","article-title":"Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications","volume":"135","author":"Shields","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.05.004_bib11","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1038\/s41433-020-01295-y","article-title":"Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma","volume":"35","author":"Xu","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2023.05.004_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2005.01.050","article-title":"Proton beam radiotherapy of iris melanoma","volume":"63","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2023.05.004_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/bjophthalmol-2012-302659","article-title":"Whole anterior segment proton beam radiotherapy for diffuse iris melanoma","volume":"97","author":"Konstantinidis","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.05.004_bib14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00417-018-3929-5","article-title":"Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects","volume":"256","author":"Riechardt","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.05.004_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ophtha.2017.10.009","article-title":"Proton beam therapy for iris melanomas in 107 patients","volume":"125","author":"Thariat","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.05.004_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/bjophthalmol-2017-310278","article-title":"Use of ruthenium-106 brachytherapy for iris melanoma: the Scottish experience","volume":"102","author":"Agraval","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.05.004_bib17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0161-6420(87)33537-7","article-title":"Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors","volume":"94","author":"Shields","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.05.004_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.oret.2022.08.026","article-title":"Proton therapy for 166 patients with iris melanoma: side effects and oncological outcome","volume":"7","author":"Gollrad","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2023.05.004_bib19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00066-017-1166-1","article-title":"Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome","volume":"193","author":"Riechardt","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ophtha.2023.05.004_bib20","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ophtha.2006.10.039","article-title":"Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27","volume":"114","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.05.004_bib21","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s004170000208","article-title":"Phacoemulsification following treatment of choroidal melanoma","volume":"238","author":"Wachtlin","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023003093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023003093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:13:50Z","timestamp":1758982430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642023003093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0161642023003093"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.05.004","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Side Effects of Proton Beam Radiotherapy Treatment on Iris Melanoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}